Direkt zum Inhalt

Case details

Case Number: App_464994/2023

  • Patent number:
    EP4087563 - COMBINATION CANCER THERAPY USING CHK INHIBITOR,
    EP4146228 - COMBINATION CANCER THERAPY USING N2-QUINOLINE OR ISOQUINOLINE SUBSTITUTED PURINE DERIVATIVES,
    EP4087561 - COMBINATION CANCER THERAPY USING CHK INHIBITOR

  • Proceeding type: Application

  • Action/Application: Inanspruchnahme der Ausnahmeregelung

  • Applicants:
    SKM-IP PartGmbB Represented by David Kuttenkeuler

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-06-01 16:27:44